Heidelberg Pharma AG (ETR:HPHA)

Heidelberg Pharma AG Ratios and Metrics

Market cap in millions EUR. Fiscal year is December - November.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 8, 2026	Nov 30, 2025	Nov 30, 2024	Nov 30, 2023	Nov 30, 2022	Nov 30, 2021
Market Capitalization	128	136	112	129	266	177
Market Cap Growth	-2.82%	21.70%	-13.03%	-51.73%	50.53%	9.59%
Enterprise Value	119	113	75	84	272	164
Last Close Price	2.73	2.91	2.40	2.76	5.72	5.18
PS Ratio	48.16	93.41	16.33	13.05	14.39	87.04
PB Ratio	-8.43	-12.47	3.62	2.61	4.00	26.43
P/TBV Ratio	-	-	5.08	3.18	4.62	-
EV/Sales Ratio	44.70	77.80	11.02	8.49	14.68	80.41
Debt / Equity Ratio	0.00	-0.01	0.01	0.12	0.24	1.59
Net Debt / Equity Ratio	0.61	1.36	-0.95	-0.76	-0.98	0.67
Net Debt / EBITDA Ratio	0.20	0.31	1.39	1.40	3.69	-0.18
Net Debt / FCF Ratio	0.31	0.47	0.97	1.09	6.92	-0.16
Asset Turnover	0.06	0.03	0.11	0.12	0.30	0.10
Inventory Turnover	0.06	0.02	0.16	0.43	1.76	9.66
Quick Ratio	1.29	1.51	4.40	2.31	2.96	0.51
Current Ratio	2.40	2.53	5.95	2.86	3.15	0.60
Return on Equity (ROE)	-820.00%	-423.92%	-48.33%	-35.09%	-53.73%	-267.02%
Return on Assets (ROA)	-70.56%	-61.88%	-20.82%	-20.14%	-18.70%	-78.14%
Return on Capital Employed (ROCE)	-216.90%	-181.70%	-41.40%	-54.50%	-25.20%	-380.20%
Earnings Yield	-31.80%	-31.06%	-17.33%	-15.82%	-7.39%	-14.77%
FCF Yield	-22.95%	-23.31%	-26.86%	-26.91%	-3.55%	-15.74%
Buyback Yield / Dilution	-0.72%	-0.14%	-0.02%	-25.14%	-14.56%	-8.72%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.